MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Merck KGaA Company Profile (OTCMKTS:MKGAY)

Consensus Ratings for Merck KGaA (OTCMKTS:MKGAY) (?)
Ratings Breakdown: 1 Sell Rating(s), 6 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Hold (Score: 2.38)
Consensus Price Target: $59.60

Analysts' Ratings History for Merck KGaA (OTCMKTS:MKGAY)
Show:
DateFirmActionRatingPrice TargetActions
5/25/2016DZ Bank AGReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016JPMorgan Chase & Co.Reiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/17/2016Citigroup Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2016Credit SuisseReiterated RatingNeutral$56.00 -> $57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2016Jefferies GroupReiterated RatingHold$51.00 -> $54.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2016Nord/LBReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2016Deutsche BankReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/6/2016Goldman SachsReiterated RatingNeutral$60.00 -> $56.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2016Bank of AmericaReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/1/2015BarclaysUpgradeEqual Weight -> Overweight$64.00 -> $66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2015ArgusReiterated RatingBuy$70.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/26/2015Societe GeneraleReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2015Piper JaffrayReiterated RatingUnderweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2015HSBCInitiated CoverageHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2015BNP ParibasInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for Merck KGaA (OTCMKTS:MKGAY)
No earnings announcements for this company have been tracked by MarketBeat.com

Earnings Estimates for Merck KGaA (OTCMKTS:MKGAY)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Merck KGaA (OTCMKTS:MKGAY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Merck KGaA (OTCMKTS:MKGAY)
No insider trades for this company have been tracked by MarketBeat.com

Latest Headlines for Merck KGaA (OTCMKTS:MKGAY)
DateHeadline
06/29/16 01:11 AMMerck Receives Frost & Sullivan Award for Meoxal® and Xirallic® NXT Lines - [at noodls] - PM_FuSAward_E News Release Your contact Nina Diergardt +49 6151 72-7589 June 29, 2016 Merck Receives Frost & Sullivan Award for Meoxal® and Xirallic® NXT Lines Product Leadership Award 2016 for staying ...
06/28/16 07:11 AMMerck Expands Industry-Leading Emprove® Program to Include Filtration and Single-Use Products - [at noodls] - b52b8ee4-b428-424a-bd99-c8d4f7e80851.pdf News Release Your Contact Karen Tiano +1 978 495 0093 June 28, 2016 Merck Expands Industry-Leading Emprove® Program to Include Filtration and Single-Use Products ...
06/28/16 04:11 AMMerck to Develop Next-Generation Purification Processes with International Vaccine Institute - [at noodls] - 8a0eeeac-8bae-453e-8244-6b9ff8747262.pdf Your Contact News Release June 28, 2016 Karen Tiano +1 978 495 0093 Company to provide expertise on clarification and purification Collaboration will improve manufacturing ...
06/25/16 08:57 AMEylea Combinations And Array's Play For Melanoma
06/20/16 01:49 PMETF’s with exposure to Merck KGaA : June 20, 2016 -
06/17/16 07:19 AMMerck Family Foundation Established - [at noodls] - Press Release Template News Release Your Contact Gangolf Schrimpf +49 6151 72-9591 June 17, 2016 The Merck family of owners combines its charitable activities under one roof ... This is an abstract of ...
06/13/16 04:49 PMMerck KGaA In Deal With HAPPYneuron To Offer E-Health Solution For MS Patients
06/13/16 02:09 AMMerck in Agreement with HAPPYneuron to Offer First-of-its Kind e-Health Solution for People Living with Multiple Sclerosis - [at noodls] - Press Release Template News Release Your Contact Stephen McGettrick +1-781-681-2104 June 13, 2016 Agreement provides Merck with exclusive license to cognitive remediation training programs ... This is ...
06/09/16 03:09 AMConsumer Health To Play A Pivotal Role In Merck’s Africa Growth Strategy - [at noodls] - 7febf971-4bc9-47c0-97f7-850fb5ddef50.pdf News Release Your Contact Lars Atorf +49 6151 856 3114 June 9, 2016 Consumer Health To Play A Pivotal Role In Merck's Africa Growth Strategy Consumer Health at ...
06/09/16 02:09 AMMerck Accelerator Expands its Reach to Silicon Valley - [at noodls] - 0d358591-11f1-4189-ad0f-743f3e568f82.pdf News Release Your Contact Annika Zille +49 151 1454 1110 June 9, 2016 Global application period for Accelerator programs in Darmstadt and Nairobi starts today ... ...
06/08/16 04:08 AMMerck Expands its Investment Fund Merck Ventures - [at noodls] - Press Release Template News Release Your Contact Gangolf Schrimpf +49 6151 72-9591 June 8, 2016 Existing biopharma venture fund renamed and expanded to all Merck business sectors ... This is an abstract ...
06/07/16 01:08 AMMerck Announces Survey Results Exploring Biopharma Industry’s Evolving Risk Model - [at noodls] - ff4b8f20-446d-410a-ba92-f1ce6af4c66b.pdf Your Contact News Release June 7, 2016 Karen Tiano +1 978 495 0093 Merck Announces Survey Results Exploring Biopharma Industry's Evolving Risk Model Study highlights ...
06/06/16 08:54 AMPfizer Says Pivotal Avelumab Study Shows Positive Results In MCC
06/06/16 08:08 AMASCO 2016: Pivotal Avelumab Study Shows Positive Results in Metastatic Merkel Cell Carcinoma - [at noodls] - Press Release Template News Release Merck Media: Gangolf Schrimpf +49 151 1454 9591 Investor Relations: +49 6151 72 3321 Pfizer Media:... This is an abstract of the original noodl. To continue reading ...
06/04/16 09:05 AMBRIEF-Merck KGaA partners with Array BioPharma, Pierre Fabre on mCRC phase iii trial - * Says partners with Array BioPharma and Pierre Fabre to initiate braf-mutant mCRC phase iii trial Further company coverage:
06/01/16 08:23 AMMerck’s Belén Garijo Receives Prestigious Career Award - [at noodls] - Press Release Template News Release Your Contact Gangolf Schrimpf +49 6151 72-9591 June 1, 2016 Merck's Belén Garijo Receives Prestigious Career Award Award from non-profit Spanish foundation Fundamed... ...
05/26/16 11:04 AMMerck KGaA :MKGAY-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016 -
05/26/16 09:43 AMCancer Immunotherapies Take Center Stage in Pre-ASCO Abstract Releases -
05/19/16 02:22 AMMerck KGaA reports Q1 results -
05/18/16 04:12 PMMerck and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting - [at noodls] - Press Release Template News Release Merck Media: Gangolf Schrimpf +49 6151 72 9591 Investor Relations: +49 6151 72 3321 Pfizer Media:... This is an abstract of the original noodl. To continue reading this ...
05/18/16 04:12 PMBringing Innovation to Patients: Merck Presents New Advances at ASCO 2016 - [at noodls] - Press Release Template News Release Merck Media: Gangolf Schrimpf +49 6151 72 9591 Investor Relations: +49 6151 72 3321 Pfizer Media:... This is an abstract of the original noodl. To continue reading this ...
05/13/16 03:08 AMGerman Image Award Goes to former Merck CEO Karl-Ludwig Kley and former Chief Communications Officer Chief Walter Huber - [at noodls] - Press Release Template News Release Your Contact Gangolf Schrimpf +49 6151 72-9591 May 13, 2016 Prize for best international media image Darmstadt, Germany, May 13, 2016 - Merck, a... This is an abstract ...
05/11/16 07:52 AMMerck Expands Popular Line of Guava® Flow Cytometers - [at noodls] - ff67fa81-b0ac-441b-8271-54f0ecd8a3e3.pdf Your Contact News Release May 11, 2016 Karen Tiano +1 978 495 0093 Merck Expands Popular Line of Guava® Flow Cytometers Optical configurations meet needs of any ...
05/10/16 09:28 AMMerck Showcases New Innovations at Analytica 2016 - [at noodls] - 049d6388-8980-48cb-b4d1-b5a253af461d.pdf News Release Your Contact Karen Tiano +1 978 495 0093 May 10, 2016 Life science expertise and innovations for simplified, dynamic and precise live cell analysis ...
05/10/16 03:08 AMMerck High-Tech for the Automotive Industry - [at noodls] - Merck Press Release Automotive Interior Stuttgart News Release Your contact Judith Rahner +49 6151 72-7694 May 10, 2016 Digital concept car featuring innovative high-tech materials to be introduced at ...
05/09/16 08:08 AMMerck and Progyny Extend Collaboration for Eeva® Software to Global Level - [at noodls] - Microsoft Word - Merck Progyny Global Collaboration_5 May 2016_final.docx News Release Your Contact Bettina Frank +49 6151 72-4660 May 09, 2016 Merck and Progyny Extend Collaboration for Eeva® Software ...
05/09/16 07:08 AMMerck Launches First Commercially Available Equine-Specific Multiplex Assay for Protein Biomarkers - [at noodls] - 125b5d02-8abc-416b-af48-4a3e86cd3c28.pdf News Release Your Contact Karen Tiano +1 978 495 0093 May 9, 2016 Merck Launches First Commercially Available Equine- Specific Multiplex Assay for Protein Biomarkers ...
05/04/16 07:10 AMMerck Builds on Leading Viral and Gene Therapy Service Offering with Capacity Expansion - [at noodls] - fa9ee4e2-810b-4b3e-bae7-ba533746593f.pdf Your Contact News Release May 4, 2016 Neetha Mahadevan 06151 726328 Larger Carlsbad, California facility will allow seamless scale-up customer support from clinical ...
05/04/16 02:10 AMMerck at SID: Materials for the Displays of Today and Tomorrow - [at noodls] - Merck SID Press Release 2016 News Release Your contact Judith Rahner +49 6151 72-7694 May 4, 2016 New materials can further optimize display properties OLED technology is... This is an abstract of the ...
03/08/16 02:20 AMUPDATE 1-Merck KGaA aims for 2016 earnings growth thanks to takeover - * Sees low double-digit percentage gain for 2016 core earnings
03/08/16 12:55 AMMerck KGaA aims for 2016 earnings growth thanks to takeover - DARMSTADT, Germany, March 8 (Reuters) - German drugs and chemicals maker Merck KGaA raised the prospect of an increase of more than 10 percent in adjusted core earnings this year, expecting...
02/23/16 04:17 AMMerck KGaA says consumer health saw 'nice' growth in 2015 - DARMSTADT, Germany, Feb 23 (Reuters) - German drugs and chemicals group Merck KGaA has seen solid growth at its consumer healthcare business last year, underpinning the family-owned company's...
02/12/16 03:26 AMUPDATE 1-UK watchdog fines GSK $54 mln over 'pay-for-delay' drug deals - * Merck KGaA also fined as former parent of generic firm (Adds details on other companies and fines, context)
01/17/16 07:07 PMGermany’s Merck KGaA Wins Battle Over Name in U.K. - FRANKFURT—Germany’s Merck MKGAY-4.52 % KGaA said Friday it has won a U.K. court ruling that prevents U.S. drug company Merck & Co. Inc. from using the Merck name in the U.K. when doing business. But the dispute isn’t over. Merck & Co. said it would ...
01/15/16 11:25 AMMerck Announces Favorable English Court Ruling on Name Use - [at noodls] - UK_Decision_EN_FinalPR News Release Your Contact Neetha Mahadevan +49 6151 72-6328 January 15, 2016 Court says MSD breached an agreement with Merck by using "Merck" alone either as a trade mark ...
01/05/16 07:01 AMWill 2016 Be Pfizer Inc.'s Best Year Yet? -
12/29/15 07:19 AMPfizer Inc.'s Best Drug in 2015 -
12/23/15 08:32 AMSigma-Aldrich Corporation -- Moody's withdraws all ratings of Sigma-Aldrich -
12/12/15 08:12 AMMeet the Miracle Cancer Drug That Cured Former President Jimmy Carter -
12/01/15 04:51 PMEuropean stocks dip on ECB doubts, US stocks rise - [AFP] - The unemployment rate in Germany is now at the lowest level since west and east reunited in 1990 after the fall of the Berlin Wall the previous year, the Federal Labour Office said in a statement
About Merck KGaA

Merck KGaA logoMerck KGaA is a Germany-based company engaged in the pharmaceutical industry. The Company diversifies its activities into four business divisions: Merck Serono; Consumer Health; Merck Millipore, and Performance Materials. Within the Merck Serono division, the Company focuses on therapeutic areas and prescription drugs of chemical and biotechnological origin. The Consumer Health division comprises the over-the-counter products for preventive health care and self-treatment of minor ailments. The Merck Serono and Consumer Health divisions form together the Company's Pharmaceutical business sector. The Merck Millipore division comprises the activities of the Millipore Corporation. The Performance Materials division consists mainly of the Liquid Crystals and Pigments & Cosmetics business units. The Company operates through numerous subsidiaries, including Peer+ BV, AZ Electronic Materials (AZ) and Ormet Circuits Inc., a material supplier for the semiconductor industry.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: MKGAY
  • CUSIP:
Key Metrics:
  • Previous Close: $31.73
  • 50 Day Moving Average: $32.725
  • 200 Day Moving Average: $30.297
  • P/E Ratio: 26.687
  • P/E Growth: 2.170
  • Market Cap: $42.68B
  • Current Quarter EPS Consensus Estimate: $6.540 EPS
Additional Links:
Merck KGaA (OTCMKTS:MKGAY) Chart for Wednesday, June, 29, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha